Loading...
Oncology Concentration And Rising R&D Costs Will Pressure Long-Term Earnings And Margins
n/a
n/a
AnalystLowTarget's Fair Value
n/a
1Y
40.6%7D
-0.6%1Y
40.6%7D
-0.6%You can edit this narrative until Dec 15 1:10 AM. Then, changes will post as Updates.